Journals / Turkish Journal of Gastroenterology / 2006 / Cilt: 17 - Sayı: 4

Kronik viral hepatitlerde kemik metabolizması ve kemik mineral yoğunluğunun değerlendirilmesi

Assessment of bone metabolism and mineral density in chronic viral hepatitis

Pages
260–266
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results suggest that chronic hepatitis B and C infections do not pose a risk for osteoporosis and low bone mineral density.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: The aim of the study was to assess bone metabolism and impact of disease on bone mineral density in patients with non-cirrhotic chronic hepatitis B or C.
📊
Key Findings & Data:Methods: 105 patients with chronic hepatitis B or C receiving antiviral agents and 60 healthy controls were included.
💡
Conclusion & Impact:Conclusion: Our results suggest that chronic hepatitis B and C infections do not pose a risk for osteoporosis and low bone mineral density.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cinsiyet faktörleri · Kemik yoğunluğu · Paratiroid hormonu

Abstract

Background/aims: The aim of the study was to assess bone metabolism and impact of disease on bone mineral density in patients with non-cirrhotic chronic hepatitis B or C. Methods: 105 patients with chronic hepatitis B or C receiving antiviral agents and 60 healthy controls were included. Subgroups (n=15) were defined on the basis of age (males) or menopausal status (females). Bone mineral density; serum parathyroid hormone (PTH), calcium (Ca), phosphorus (P), total alkaline phosphatase, and 25-hydroxy vitamin D levels; 24-hour urinary levels of Ca and P; and urinary telopeptide (NTX) were measured. Statistical comparisons were made between patient groups and the matched controls. Results: Compared to controls, the average serum levels of PTH were lower and 24-hour urinary mean Ca levels and T scores were higher in chronic hepatitis B patients between 20 and 40 years of age. Men with chronic hepatitis B and aged 40 - 65 years had lower mean serum P concentrations. Postmenopausal women with chronic hepatitis B had significantly higher NTX levels. Men with chronic hepatitis C had significantly elevated levels of 24-hour mean urinary P levels. The serum 25 OH vitamin D levels were significantly higher in premenopausal women with chronic hepatitis C. Postmenopausal women with chronic hepatitis C had significantly lower serum P concentrations. Other parameters and T scores did not differ significantly between patient groups and matched controls. Conclusion: Our results suggest that chronic hepatitis B and C infections do not pose a risk for osteoporosis and low bone mineral density.

Özet

Amaç: Bu çalışmanın amacı sirotik olmayan kronik B ve kronik C hepatitli hastalarda kemik metabolizmasını değerlendirmek ve hastalığın kemik mineral yoğunluğu üzerine etkisini araştırmaktır. Yöntem: Çalışmaya, antiviral ilaçlarla tedavi edilen, nonsirotik 105 kronik B ve C hepatitli hasta ile 60 sağlıklı kişi kontrol grubu alındı. Hastalar; kronik B hepatit, kronik C hepatit ve sağlıklı kontrol grubu olmak üzere 3 ana gruba ayrıldı. Subgruplar (n=15 ) yaşa (Erkek), menapozal duruma (kadın) göre tanımlandı. Kemik mineral dansitesi ,serum paratiroid hormon, kalsiyum, fosfor, total alkalen fosfataz, 25 hidroksi D vitamini ve 24 saatlik idrar kalsiyum ve fosfor, üri-ner telopeptid (NTX) düzeyleri tespit edildi. Tüm hasta grupları ile kontrol grupları bu paremetreler açısından kıyaslanarak istatistiksel olarak anlamlı fark arandı. Bulgular: Kontrol grubu ile karşılaştırıldığında, 20-40 yaş arası kronik B hepatitli hastaların serum PTH değeri ortalaması daha düşük, 24 saatlik üriner Ca değeri ortalaması daha yüksek ve T skoru ortalaması da daha yüksek bulundu. 40-65 yaş arası erkek kronik B hepatitli hastaların serum P değeri ortalaması daha düşüktü. Postmenapoz kronik B hepatitli hastaların üriner NTX düzeyi anlamlı derecede yüksekti Kronik C hepatitli erkek hastaların 24 saatlik üriner P düzeyi ortalaması anlamlı olarak yüksekti. Premenapoz kronik C hepatitli hastaların serum 25 OH D vitamini düzeyi ortalaması kontrol grubuna göre anlamlı derecede yüksek bulundu. Postmenapoz kronik C hepatitli hastaların serum P düzeyi ortalaması postmenapoz kontrol grubundakinden anlamlı olarak düşük bulundu. Diğer labora-tuvar parametreler ve T skoru ölçümleri kontrol grupları ile kıyaslandığında istatistiksel olarak anlamlı fark tespit edilmedi. Sonuç: Çalışma kronik C hepatit ve kronik B hepatitin osteopo-roz ve düşük kemik mineral yoğunluğu için bir risk faktörü olmadığını göstermiştir.

🔖

Cite This Article

YENİCE, N., GÜMRAH, M., MEHTAP, Ö., KOZAN, A., TÜRKMEN, S. (2006). Kronik viral hepatitlerde kemik metabolizması ve kemik mineral yoğunluğunun değerlendirilmesi. Turkish Journal of Gastroenterology, Cilt: 17 - Sayı: 4, 260–266. https://ajindex.com/articles/410006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tsuneoka K, Tameda Y, Takase K, Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996; 31: 669-78
  2. Trautwein C, Possinke M, Schlitt HJ, et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 2000; 95: 2343-51
  3. Casini A, Mohamed EI, Gandin C, et al. Predicting bone mineral density of postmenopausal healthy and cirrhotic Italian women using anthropometric variables. Dig Liver Dis 2003; 35: 881-7
  4. Carey EJ, Balan V, Kremers WK, Hay JE. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl 2003; 9: 1166-73
  5. Collier JD, Ninkovich M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002; 50: 1-9
  6. Idilman R, de Maria N, Uzunalimoglu O, van Thiel DH. Hepatic osteodystrophy: a review. Hepatogastroenterology 1997; 44: 574-81
  7. Crosbie OM, Freaney R, Mc Kenna MJ, Hegarty JE. Bone density, vitamin D status and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 1999; 64: 295-300
  8. Compston J. The effect of liver disease on bone. In: McIntyre N, Benhammou JP, Bircher J, et al., eds. Oxford Textbook of Hepatology. Oxford: Oxford University Press, 1991
  9. Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001; 16: 1022-7
  10. Ormarsdottir S, Ljunggren O, Mallmin H, et al. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol 2002; 14: 43-8
  11. Mobarhan SA, Russell RM, Recker RR, et al. Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D or supportive treatment. Hepatology 1984; 4: 266-73
  12. Masudo S, Okana T, Osawa K, et al. Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo) 1989; 35: 225-34
  13. Jorge-Hernandez JA, Gonzales-Reimers CE, Torres-Ramirez A, et al. Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis in 52 patients. Dig Dis Sci 1988; 33: 1089-95
  14. Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clini